ENDOCRINE DISRUPTORS AND THE EPIGENOME

J. Greally

Abstract:1. The mechanism by which the group of chemicals referred to as „endocrine disruptors‟ exert their phenotypic effects remains unknown, but there is emerging evidence that dysregulation of the cell‟s epigenome is involved. In the last decade, it has become clear that the emerging field of epigenetics is of significant relevance for both the study and practice of toxicology and safety assessment. At the research level, these efforts currently aim to elucidate the involvement of chemical-induced epigenetic changes in adverse health effects, as well as to the exploitation of epigenetics particularly in the area of in vitro and in vivo modeling. This chapter reviews our current understanding of the intersection of these two fields of research and proposes avenues of exploration encompassing epigenetic information that will form the foundation for definitive testing of this relationship and provide a basis for future practical applications for regulatory safety assessment. 2. How to eventually incorporate the understanding of these mechanisms into the OECD chemical safety assessment regulatory activities, in the ED conceptual framework screening, priority and definitive testing levels, is the major challenge and objective that this chapter will begin to explore and address.